ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,249.34
-1.03%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.645
-0.02%
Brent Oil
83.76
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Stealth BioTherapeutics Corporation (MITO)

  7. Stealth BioTherapeutics Corporation (MITO) ニュース

MITO

Stealth BioTherapeutics (MITO)

Stealth BioTherapeutics Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:MITO
日付受信時刻ニュースソース見出しコード企業名
2022/11/2908 : 41Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/11/1706 : 23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/11/1706 : 22Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/11/1706 : 20Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/11/1706 : 19Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/11/1706 : 16Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/11/1706 : 14Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/11/1706 : 10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/11/1706 : 08Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/11/1706 : 01PR Newswire (US)Stealth BioTherapeutics Corp Announces Completion of MergerNASDAQ:MITOStealth BioTherapeutics Corporation
2022/11/0120 : 30PR Newswire (US)Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/10/0805 : 01PR Newswire (US)Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of ShareholdersNASDAQ:MITOStealth BioTherapeutics Corporation
2022/10/0106 : 01TipRanksStealth Biotherapeutics announces resignation of CFO Robert WeiskopfNASDAQ:MITOStealth BioTherapeutics Corporation
2022/10/0106 : 00PR Newswire (US)Stealth BioTherapeutics Announces Departure of Chief Financial OfficerNASDAQ:MITOStealth BioTherapeutics Corporation
2022/09/2406 : 21Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/09/1605 : 45PR Newswire (US)Stealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease EventsNASDAQ:MITOStealth BioTherapeutics Corporation
2022/08/2005 : 16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/08/1922 : 50Edgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/08/0205 : 46Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/08/0122 : 48Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/08/0121 : 30PR Newswire (US)Stealth BioTherapeutics Corp Enters Definitive Agreement for Going Private TransactionNASDAQ:MITOStealth BioTherapeutics Corporation
2022/07/1206 : 21Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/07/1206 : 15PR Newswire (US)STEALTH BIOTHERAPEUTICS ANNOUNCES RECEIPT OF NON-COMPLIANCE NOTICE FROM NASDAQNASDAQ:MITOStealth BioTherapeutics Corporation
2022/06/2805 : 50Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/06/2723 : 25AllPennyStocks.comPremarket Indicating Higher Open For This BiotechNASDAQ:MITOStealth BioTherapeutics Corporation
2022/06/2721 : 02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/06/2720 : 30PR Newswire (US)Stealth BioTherapeutics Corp Announces Receipt of Preliminary Non-Binding ProposalNASDAQ:MITOStealth BioTherapeutics Corporation
2022/06/1619 : 15TipRanksH.C. Wainwright Thinks Stealth Biotherapeutics’ Stock is Going to RecoverNASDAQ:MITOStealth BioTherapeutics Corporation
2022/06/1619 : 05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MITOStealth BioTherapeutics Corporation
2022/06/1420 : 25PR Newswire (US)Stealth BioTherapeutics Granted Pre-NDA Meeting for Elamipretide as a Potential Treatment for Barth SyndromeNASDAQ:MITOStealth BioTherapeutics Corporation
 Showing the most relevant articles for your search:NASDAQ:MITO

最近閲覧した銘柄

NASDAQ
MSBI
Midland States Bancorp
BIT
P1QSO0
BNP Paribas Issuance
BIT
F37303
Vontobel Financial Produ...
AMEX
GEMD
Goldman Sachs Access Eme...
EU
UTI
Amundi ST EU Utilities
BIT
F19156
Vontobel Financial Produ...
BIT
F34603
Vontobel Financial Produ...
BIT
F38462
Vontobel Financial Produ...
BIT
F34584
Vontobel Financial Produ...
BIT
P1D7J4
BNP Paribas Issuance
BIT
P1IA93
BNP Paribas Issuance
BIT
F38714
Vontobel Financial Produ...
BIT
P1DGO3
BNP Paribas Issuance
BIT
F17722
Vontobel Financial Produ...
USOTC
MEIYF
Mercialys Paris (PK)
BIT
P1RJ28
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有